Inspiratory muscle training for people recovering from COVID-19
Efficacy of Inspiratory Muscle Training (IMT) on Sleep Quality, Exercise Tolerance and Pulmonary Radioaerosol Deposition Pattern in Post COVID-19 Infection Subjects
This study is testing if inspiratory muscle training can help people recovering from COVID-19 improve their breathing, sleep, and overall quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Universidade Federal de Pernambuco Academic / other |
| Locations | 1 site (Recife, Pernambuco) |
| Trial ID | NCT05282199 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of inspiratory muscle training in individuals recovering from COVID-19, focusing on improving their aerobic capacity, respiratory muscle strength, sleep quality, and overall quality of life. Participants will undergo pulmonary function tests and manovacuometry before and after an 8-week training program. The study aims to fill a gap in the literature regarding the benefits of this intervention for long-term COVID symptoms. It is a quasi-experimental study involving elderly volunteers over 18 years of age residing in Recife, Pernambuco.
Who should consider this trial
Good fit: Ideal candidates are individuals over 18 years old who have tested positive for COVID-19 and are within 10 days post-hospital discharge.
Not a fit: Patients with pre-existing orthopedic, neurological, cardiovascular, or respiratory conditions, as well as those currently infected with COVID-19, will not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the quality of life and respiratory function for patients recovering from COVID-19.
How similar studies have performed: While inspiratory muscle training has been used in various contexts, this specific application for long-term COVID symptoms is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients of all genders, over 18 years of age, who are not undergoing any type of post-infection treatment, with a diagnosis through RT-PCR positive for the Coronavirus, who fall within the period of up to 10 days after hospital discharge will be included. . Exclusion Criteria: * Individuals with previous orthopedic, neurological problems or any cardiovascular or respiratory disease in their clinical history, pregnant women and patients in the active phase of infection for the coronavirus, or who cannot maintain proper positioning during the scintigraphy exam will be excluded pulmonary
Where this trial is running
Recife, Pernambuco
- Universidade Federal de Pernambuco — Recife, Pernambuco, Brazil (Recruiting)
Study contacts
- Principal investigator: ARMELE DORNELAS DE ANDRADE, PhD — Universidade Federal de Pernambuco
- Study coordinator: Jose Carlos N Nobrega Junior, M.d.
- Email: c10carlo@gmail.com
- Phone: (81) 99559-5803
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.